BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Diagnosis
114 results:

  • 1. Integrating single-cell and spatial transcriptomes reveals COL4A1/2 facilitates the spatial organisation of stromal cells differentiation in breast phyllodes tumours.
    Li X; Yu X; Bi J; Jiang X; Zhang L; Li Z; Shao M
    Clin Transl Med; 2024 Mar; 14(3):e1611. PubMed ID: 38481388
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Barriers and facilitators of artificial intelligence conception and implementation for breast imaging diagnosis in clinical practice: a scoping review.
    Lokaj B; Pugliese MT; Kinkel K; Lovis C; Schmid J
    Eur Radiol; 2024 Mar; 34(3):2096-2109. PubMed ID: 37658895
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Initial Evaluation of [
    Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
    J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A2/B1 Promotes NRF2 mRNA Stability and Inhibits Ferroptosis and Cell Proliferation in breast cancer Cells.
    Huang Y; Chen J; Pan J; Yang Y; Huang H; Lai H; Yang L; Ai H
    Biomed Res Int; 2023; 2023():2620738. PubMed ID: 37090185
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Signet ring cell-like diffuse large B-cell lymphoma involving the breast: a case report.
    Zhang L; Min Q; Bi J; Yu X; Liang Y; Shao M
    BMC Womens Health; 2023 Mar; 23(1):119. PubMed ID: 36949419
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Novel therapeutics in low-grade serous ovarian cancer.
    Cobb L; Gershenson D
    Int J Gynecol Cancer; 2023 Mar; 33(3):377-384. PubMed ID: 36878564
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Central nervous system involvement at initial diagnosis of extranodal NK/T-cell lymphoma: a retrospective study of a consecutive 12-year case series.
    Wu W; Ren K; Li N; Luo Q; Zhou H; Hai T; Zou L
    Ann Hematol; 2023 Apr; 102(4):829-839. PubMed ID: 36729147
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Case report: Amphiphysin-IgG autoimmunity: a paraneoplastic presentation of appendiceal goblet cell carcinoma.
    Lin J; Yu T; Wang M; Wang J; Li J
    Front Immunol; 2022; 13():1001264. PubMed ID: 36685551
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis.
    Kathrikolly T; Nair SN; Mathew A; Saxena PPU; Nair S
    Syst Rev; 2022 Oct; 11(1):215. PubMed ID: 36210467
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
    Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A comparative study of diagnostic accuracy in 3026 pleural biopsies and matched pleural effusion cytology with clinical correlation.
    Poon IK; Chan RCK; Choi JSH; Ng JKM; Tang KT; Wong YYH; Chan KP; Yip WH; Tse GM; Li JJX
    Cancer Med; 2023 Jan; 12(2):1471-1481. PubMed ID: 35848750
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. HNRNPA2B1 Demonstrates Diagnostic and Prognostic Values Based on Pan-cancer Analyses.
    Chen C; Huang L; Sun Q; Yu Z; Wang X; Bu L
    Comput Math Methods Med; 2022; 2022():9867660. PubMed ID: 35529270
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study.
    Bouferraa Y; Haibe Y; Chedid A; Jabra E; Charafeddine M; Temraz S; Mukherji D; El Saghir N; Shamseddine A
    BMC Cancer; 2022 Jan; 22(1):27. PubMed ID: 34980002
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Quantitative single-cell analysis of immunofluorescence protein multiplex images illustrates biomarker spatial heterogeneity within breast cancer subtypes.
    Cheung AM; Wang D; Liu K; Hope T; Murray M; Ginty F; Nofech-Mozes S; Martel AL; Yaffe MJ
    Breast Cancer Res; 2021 Dec; 23(1):114. PubMed ID: 34922607
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Primary breast cd20-positive extranodal NK/T cell lymphoma with stomach involvement: a case report and literature review.
    Zhang Y; Wang K; Tan Q; Yang K; Wu D; Xu Y; Zhao X; Jiang Z
    Diagn Pathol; 2021 Nov; 16(1):103. PubMed ID: 34749754
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. IL13Rα2 Promotes Proliferation and Outgrowth of breast cancer Brain Metastases.
    Márquez-Ortiz RA; Contreras-Zárate MJ; Tesic V; Alvarez-Eraso KLF; Kwak G; Littrell Z; Costello JC; Sreekanth V; Ormond DR; Karam SD; Kabos P; Cittelly DM
    Clin Cancer Res; 2021 Nov; 27(22):6209-6221. PubMed ID: 34544797
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Differential effects of cd20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients.
    Arias-Pulido H; Cimino-Mathews AM; Chaher N; Qualls CR; Joste N; Colpaert C; Marotti JD; Chamberlin MD; Foisey MG; Prossnitz ER; Emens LA; Fiering S
    Breast Cancer Res Treat; 2021 Dec; 190(3):477-489. PubMed ID: 34542773
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparative Characterization of Lymphoid Infiltration in Different Molecular-Biological Subtypes of Invasive breast cancer.
    Erofeeva LM; Mnikhovich MV
    Bull Exp Biol Med; 2021 May; 171(1):62-67. PubMed ID: 34046792
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Primary Mucinous Cystadenocarcinoma of the breast: A Rare Case Report With Review of Literature.
    Jain E; Kumar A; Jain R; Sharma S
    Int J Surg Pathol; 2021 Oct; 29(7):740-746. PubMed ID: 33635116
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancer.
    Sumazaki M; Ogata H; Nabeya Y; Kuwajima A; Hiwasa T; Shimada H
    Cancer Sci; 2021 May; 112(5):1955-1962. PubMed ID: 33605508
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.